Alphaeon Corp. announced its acquisition of Clarion Medical Technologies, a provider of medical and aesthetic equipment and consumable products, for $55 million, according to a press release.
The deal includes a combination of cash and equity, and performance-based earn outs, the release stated. Clarion, formerly known as Coherent-AMT, has operated in Canada since 1989, and has more than 100 employees, 36 sales representatives and 40 product licenses.
“We are excited to have Clarion join Alphaeon,” Robert E. Grant, chief executive officer of Alphaeon, said in the release. “We view Clarion as a leading provider of lifestyle health care products in Canada and are thrilled to combine their products and experience with our platform.”
“In Alphaeon, we have found a company whose values and approach to working with physicians and clinics align with ours,” Dan Webb, founder and chairman of Clarion, said in the release.
Alphaeon is a subsidiary of Strathspey Crown Holdings, a growth equity firm that specializes in lifestyle health care, whose investors include physician specialists in plastic surgery, dermatology, ophthalmology, dentistry and orthopedics.